| MR编号 | DE/H/6388/001 |
|---|
| 药品名称 | Cibastyn 136 mmol/l Infusionslösung |
|---|
| 活性成分 | - TRISODIUM CITRATE dihydrate 136.0 mmol/l
|
|---|
| 剂型 | Solution for infusion |
|---|
| 上市许可持有人 | Fresenius Medical Care Deutschland GmbH
Else-Kroener-Strasse 1
61352 Bad Homburg
Germany |
|---|
| 参考成员国 - 产品名称 | Germany (DE) Cifoban 136 mmol/l Infusionslösung |
|---|
| 互认成员国 - 产品名称 | - Greece (GR)
- Lithuania (LT)
Cigenta 136 mmol/l infuzinis tirpalas - Ireland (IE)
- United Kingdom (Northern Ireland) (XI)
- Latvia (LV)
Civaron 136 mmol/l šķīdums infūzijām - Luxembourg (LU)
- Croatia (HR)
- Poland (PL)
Cifoban - Netherlands (NL)
- Finland (FI)
- Belgium (BE)
Civastyn 136 mmol/l oplossing voor infusie - Norway (NO)
- Denmark (DK)
- Slovakia (SK)
- Sweden (SE)
- Romania (RO)
Cifoban 136 mmol/l soluţie perfuzabilă - Czechia (CZ)
Cifoban 136 mmol/l infuzní roztok - Italy (IT)
- Cyprus (CY)
Cifoban 136mmol/l διάλυμα για έγχυση - Portugal (PT)
- Spain (ES)
- France (FR)
- Estonia (EE)
- Slovenia (SI)
- Bulgaria (BG)
- Hungary (HU)
- Austria (AT)
|
|---|
| 许可日期 | 2021/10/27 |
|---|
| 最近更新日期 | 2023/10/23 |
|---|
| 药物ATC编码 | | 申请类型 | - TypeLevel1：Known Active Substance
- TypeLevel2：Initial Application
- TypeLevel3：Bibliographic Art 10 a Dir 2001/83/EC
- TypeLevel4：Chemical Substance
- TypeLevel5：Prescription Only
|
|---|
| 附件文件下载 | |
|---|
| 市场状态 | Positive |
|---|
|
|---|